Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-006406)

Filing Details

Accession Number:: 0001209191-12-006406
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-01-31 17:59:38
Reporting Period:: 2012-01-27

Filing Date:: 2012-01-31
Accepted Time:: 2012-01-31 17:59:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1034196	Advent International Corp/Ma	75 State Street, 29Th Floor Boston MA 02109		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-01-27	50,000	$17.17	2,582,879	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2012-01-30	2,700	$17.06	2,580,179	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2012-01-31	22,300	$17.10	2,557,879	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

These securities are indirectly beneficially owned in the following capacities; as Manager of Advent International LLC, which in turn is the General Partner of AHLS III GP, which in turn is the General Partner of Advent Healthcare & Life Sciences III Limited Partnership and Advent Healthcare & Life Science III A Limited Partnership. Advent International Corporation is also the General Partner of Advent Partners HLS III Limited Partnership.